Cutler Group’s Ingevity NGVT Stock Holding History

Cutler Group’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-300	Closed	-$2K	–	6071
2020 Q4	$2K	Buy	+300	New	+$19.5K	﹤0.01%	4202

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

AAM

Ardevora Asset Management London, United Kingdom $1.12B AUM 26.09% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cutler Group's NGVT Position: Q2 2021 in Review

Cutler Group sold out of Ingevity (NGVT) in Q2 2021, closing a stake of 200 shares — an estimated $15K sold.

Cutler Group first reported a position in NGVT in Q2 2016 and held it in 9 quarters. The position peaked at $71K in Q2 2016. 277 funds tracked by Wall St. Rank hold NGVT as of Q2 2021.

Cutler Group reported no remaining Ingevity position as of Q2 2021 after selling out during the quarter.
Cutler Group sold 200 Ingevity shares in Q2 2021, an estimated $15K.
Cutler Group first reported a position in Ingevity in Q2 2016 and held it in 9 quarters.
Cutler Group's Ingevity position peaked at $71K in Q2 2016.
277 funds tracked by Wall St. Rank held Ingevity as of Q2 2021.

Based on Cutler Group's 13F filing for Q2 2021, filed 19 Jul 2021.